Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06918392 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Field-test and Psychometric Validation of the Pectus Excavatum Evaluation Questionnaire in the Dutch Pectus Excavatum Population

Study acronym: TRANSLATE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Zuyderland Medisch Centrum to Erik de Loos
    • Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 1, 2025 to Dec 15, 2021
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A questionnaire that can measure disease severity from the patients perspective in patients with pectus excavatum already exists in English (Pectus Excavatum Evaluation Questionnaire; PEEQ). This questionnaire was recently translated into Dutch. Before this Dutch version can be used, it needs to be tested by a number of patients. Data will be collected at three moments: 1. Preoperatively: The PEEQ will be completed on paper during the outpatient clinic visit. 2. Postoperatively: The PEEQ will be completed electronically 2 months post-surgery. 3. Test-retest reliability: The PEEQ will be administered electronically at least two weeks after a previous assessment.
Trial Details
NCT Number NCT06918392
Lead Sponsor Erik de Loos
Conditions
(from sponsor)		 Pectus Excavatum
Related terms Funnel Chest
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov